[go: up one dir, main page]

NO20083064L - Fremgangsmate for fremstilling av et farmasoytisk mellomprodukt - Google Patents

Fremgangsmate for fremstilling av et farmasoytisk mellomprodukt

Info

Publication number
NO20083064L
NO20083064L NO20083064A NO20083064A NO20083064L NO 20083064 L NO20083064 L NO 20083064L NO 20083064 A NO20083064 A NO 20083064A NO 20083064 A NO20083064 A NO 20083064A NO 20083064 L NO20083064 L NO 20083064L
Authority
NO
Norway
Prior art keywords
preparation
enantiomers
formula
pharmaceutical intermediate
levocetirizine
Prior art date
Application number
NO20083064A
Other languages
English (en)
Inventor
Zoltan Katona
Gyorgyi Vereczkeyne Donath
Peter Trinka
Jozsef Reiter
Ferenc Bartha
Original Assignee
Egis Gyogyszergyar Nyilvanosan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyilvanosan filed Critical Egis Gyogyszergyar Nyilvanosan
Publication of NO20083064L publication Critical patent/NO20083064L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Fremgangsmåte for fremstilling av {2-[4-(a-fenyl-/?-klorbenzyl)-piperazin-l-yl]-etoksy}-eddiksyre-A^7V-dimetylamid av formel (I) og enantiomerer derav. Forbindelsen av formel (Kl) eller enantiomerer derav er viktige farmasøytiske mellomprodukter egnet for direkte omdannelse til ikke-sedasjonsgivende farmasøytisk aktive ingredienser av antihistamintypen cetirizin og levocetirizin.
NO20083064A 2005-12-08 2008-07-08 Fremgangsmate for fremstilling av et farmasoytisk mellomprodukt NO20083064L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0501138A HU227325B1 (en) 2005-12-08 2005-12-08 Process for the production of an intermediate of (dextro- and levo)- cetirizine
PCT/HU2006/000108 WO2007066162A1 (en) 2005-12-08 2006-12-08 Process for the preparation of a pharmaceutical intermediate

Publications (1)

Publication Number Publication Date
NO20083064L true NO20083064L (no) 2008-07-08

Family

ID=89986438

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083064A NO20083064L (no) 2005-12-08 2008-07-08 Fremgangsmate for fremstilling av et farmasoytisk mellomprodukt

Country Status (11)

Country Link
US (1) US20090018337A1 (no)
EP (1) EP1971585B1 (no)
JP (1) JP2009518378A (no)
CN (1) CN101360727A (no)
AT (1) ATE501131T1 (no)
DE (1) DE602006020624D1 (no)
EA (1) EA014530B1 (no)
HU (1) HU227325B1 (no)
NO (1) NO20083064L (no)
UA (1) UA92770C2 (no)
WO (1) WO2007066162A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007012041A2 (en) 2005-07-20 2007-01-25 Lab Partners Associates, Inc. Wireless photographic communication system and method
WO2008150902A1 (en) 2007-05-29 2008-12-11 Lab Partners Associates, Inc. System and method for maintaining hot shoe communications between a camera and a wireless device
KR20100059836A (ko) * 2007-08-15 2010-06-04 케마지스 리미티드 고순도 레보세티리진 및 이의 염을 제조하기 위한 신규한 방법
CN103044355A (zh) * 2011-10-13 2013-04-17 湖南九典制药有限公司 合成左西替利嗪的关键中间体及其制备方法
CN110988163B (zh) * 2019-11-29 2022-04-19 重庆华邦胜凯制药有限公司 一种hplc法分离测定盐酸左西替利嗪及其基因毒性杂质e的方法
CN111205247B (zh) * 2020-04-22 2020-08-14 湖南九典宏阳制药有限公司 左旋西替利嗪的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
GB8827391D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US20030064995A1 (en) * 2001-10-03 2003-04-03 Merck Patent Gmbh Amide and urea derivatives as 5-HT reuptake inhibitors and as5-HT1B/1D ligands
IL124195A (en) * 1998-04-23 2000-08-31 Chemagis Ltd Process for the preparation of esters of 2-¬4-¬4-chlorophenyl¾phenylmethyl¾-1-piperazinyl¬ethoxy¾acetic acid
EP1233954B1 (en) * 1999-11-30 2004-10-20 Egis Gyogyszergyar Rt. A process for the preparation of 2- 4-(alpha-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxy acetic acid and novel intermediates therefor

Also Published As

Publication number Publication date
HUP0501138A2 (en) 2007-08-28
EP1971585A1 (en) 2008-09-24
HU0501138D0 (en) 2006-02-28
CN101360727A (zh) 2009-02-04
HU227325B1 (en) 2011-03-28
UA92770C2 (ru) 2010-12-10
DE602006020624D1 (de) 2011-04-21
US20090018337A1 (en) 2009-01-15
EA200801505A1 (ru) 2008-10-30
JP2009518378A (ja) 2009-05-07
EP1971585B1 (en) 2011-03-09
ATE501131T1 (de) 2011-03-15
EA014530B1 (ru) 2010-12-30
WO2007066162A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
NO20083064L (no) Fremgangsmate for fremstilling av et farmasoytisk mellomprodukt
MY148643A (en) Solvate and crystalline forms of carbamoyl-cyclohexane derivatives
NO20060110L (no) Spesifik glukokortikosteroid forbindelse med anti-inflammatorisk aktivitet
NO20080789L (no) 1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid
NO20090229L (no) 1-[2-(2,4-dimetylfenylsulfanyl-fenyl]-piperazin som en forbindelse med kombinert serotoninreopptak, 5-HT3- og 5HT1A-aktivitet for behandlingen av kognitiv smerte
NO20072605L (no) Nytt antranilinsyrederivat eller et salt derav
HRP20060254A2 (en) Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
NO20083114L (no) Polysykliske indazolderivater som er ERK-inhibitorer
HRP20050070B1 (hr) 3-2-[1-(4-(n-((4-metil-piperazin-1-il)-metilkarbonil)-n-metil-amino)-anilino)-1-fenil-metilen]-6-metoksikarbonil-2-indolinon-monoetansulfonat i njegova primjena kao farmaceutskog pripravka
NO20080186L (no) Heterosykliske aspartylproteaseinhibitorer, fremstilling og anvendelse derav
BRPI0514738A (pt) derivados de amida de 3-fenil-diidropirimido[4,5-d]pirimidinonas, sua fabricação e aplicação como agentes farmacêuticos
CY1110358T1 (el) Υποκατεστημενα παραγωγα προπενυλ πιπεραζινης ως νεοι αναστολεις της αποακετυλασης ιστονης
BR0306922A (pt) N-pirazinil-fenilsulfonamidas e seu uso no tratamento de doenças mediadas por quimocina
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
MX2010008583A (es) Novedosos formas cristalinas de acido 4-[4-(2-adamantilcarbamoil)- 5-ter-butil-pirazol-1-il]benzoico.
US20210251942A1 (en) 2-naphthimidamides, analogues thereof, and methods of treatment using same
NO20070565L (no) Kinolin tiazolinoner med CDK1 antiproliferativ aktivitet
ATE457302T1 (de) Aromatische etherderivate als thrombin-hemmer
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen
WO2008139492A3 (en) A process for the preparation of highly pure ranolazine base
BR0108501A (pt) Compostos de n-hidróxiformamidas substituìdos por piperidina e piperazina como agentes inibidores de metaloproteinase
TW200616952A (en) Novel crystal form of (3-cyano-1h-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]-methanone, hydrochloride
WO2007066163A3 (en) Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates
NO20075766L (no) Aminoalkyl-amidometyl-substituerte 2-(4-sulfonylamino)-3-hydroksy-3,4-dihydro-2H-kromen-6-yl-derivater og deres anvendelse som kaliumkanalblokkere
NO20080839L (no) Isotopsubstituerte protonpumpeinhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application